EIGER BIOPHARMACEUTICALS, INC. (NASDAQ: EIGR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR)
December 20, 2022 12:30 ET
|
Bernstein Liebhard LLP
Did you lose money on investments in Eiger BioPharmaceuticals, Inc.? If so, please visit Eiger BioPharmaceuticals, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...
DEADLINE ALERT for EIGR, TSP, and UIS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
December 20, 2022 12:00 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Dec. 20, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
ROSEN, A LEADING NATIONAL FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EIGR
December 19, 2022 12:33 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 19, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) between...
EIGER ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm
December 16, 2022 22:53 ET
|
Bragar Eagel & Squire
NEW YORK, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
DEADLINE ALERT for FIGS, EVA, EIGR, TSP: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
December 15, 2022 11:00 ET
|
Law Offices of Howard G. Smith
BENSALEM, Pa., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EIGR
December 14, 2022 16:12 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 14, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) between...
DEADLINE ALERT for EIGR, TSP, and UIS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
December 13, 2022 12:02 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Dec. 13, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
DEADLINE ALERT for EIGR, TSP, and UIS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
December 08, 2022 12:15 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Dec. 08, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
EIGER BIOPHARMACEUTICALS, INC. (NASDAQ: EIGR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR)
December 06, 2022 16:00 ET
|
Bernstein Liebhard LLP
Did you lose money on investments in Eiger BioPharmaceuticals, Inc.? If so, please visit Eiger BioPharmaceuticals, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EIGR
December 05, 2022 12:38 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 05, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) between...